Treatment of Infectious Mononucleosis
Infectious mononucleosis is primarily managed with supportive care as there is no specific antiviral therapy proven to alter the course of the disease in immunocompetent individuals. 1, 2
Diagnosis Confirmation
Before initiating treatment, confirm diagnosis with:
- Clinical presentation: Triad of fever, tonsillar pharyngitis, and lymphadenopathy 2
- Laboratory findings:
Standard Treatment Approach
First-line Management
- Supportive care:
Activity Restrictions
- Avoid contact sports or strenuous exercise for at least 8 weeks or while splenomegaly is present to prevent splenic rupture (occurs in 0.1-0.5% of cases) 2
Monitoring
- Monitor for complications including:
Special Circumstances
Severe Symptoms or Complications
- Corticosteroids may be beneficial in cases of:
Immunocompromised Patients
- In immunocompromised patients with severe EBV infection:
What NOT to Do
- Acyclovir is not recommended for routine treatment of infectious mononucleosis in immunocompetent individuals as meta-analyses of clinical trials have shown no benefit 1, 3
- Avoid routine antibiotic use unless there is evidence of bacterial superinfection
- Do not enforce strict bed rest 3
Duration and Follow-up
- Most symptoms resolve within 2-4 weeks
- Fatigue may persist for several months after the acute infection 2, 3
- Follow-up to ensure resolution of splenomegaly before clearing patient for contact sports
Common Pitfalls
- Misdiagnosing streptococcal pharyngitis as infectious mononucleosis (or vice versa)
- Prescribing amoxicillin/ampicillin, which can cause a maculopapular rash in EBV-infected patients
- Failing to counsel patients about the risk of splenic rupture and the need to avoid contact sports
- Overuse of corticosteroids in uncomplicated cases
- False-negative heterophile antibody tests early in the course of infection 3